Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -544.06% is 99% above its 5-year average of -58068.45%, near the high end of its 5-year range (-134313.33%–-49.03%).
99.21% above its 12-month average of -68939.70%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -44760.21%.
NET PROFIT MARGIN
-544.06%
NET PROFIT MARGIN AVG TTM
-68939.70%
NET PROFIT MARGIN AVG 3Y
-84015.37%
NET PROFIT MARGIN AVG 5Y
-58068.45%
NET PROFIT MARGIN AVG 10Y
-34343.16%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+99.21%
CURRENT VS 3Y AVG
+99.35%
CURRENT VS 5Y AVG
+99.06%
CURRENT VS 10Y AVG
+98.42%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-155345.71%
vs the sector median at left
Viridian Therapeutics, Inc.
Market Cap
$2.06B
Net Profit Margin
-544.06%
TTM Avg
-68939.70%
3Y Avg
-84015.37%
5Y Avg
-58068.45%
Market Cap
$2.06B
Net Profit Margin
-268385.71%
TTM Avg
-9751.05%
3Y Avg
-6580.61%
5Y Avg
-4774.06%
Market Cap
$2.08B
Net Profit Margin
-36.51%
TTM Avg
-21.30%
3Y Avg
-316.14%
5Y Avg
-299.31%
Market Cap
$2.05B
Net Profit Margin
7.91%
TTM Avg
5.18%
3Y Avg
-0.36%
5Y Avg
-0.65%
Market Cap
$2.02B
Net Profit Margin
-40.90%
TTM Avg
5.22%
3Y Avg
-37.29%
5Y Avg
-215.44%
Market Cap
$2.11B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1032.53%
5Y Avg
-880.74%
Market Cap
$2.02B
Net Profit Margin
-51.73%
TTM Avg
-140.08%
3Y Avg
-143.59%
5Y Avg
-315.66%
Market Cap
$2.02B
Net Profit Margin
100.84%
TTM Avg
51.96%
3Y Avg
-5.31%
5Y Avg
-103.82%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Viridian Therapeutics, Inc. (VRDN) | $2.06B | -544.06% | -68939.70% | -84015.37% | -58068.45% |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.06B | -268385.71% | -9751.05% | -6580.61% | -4774.06% |
| Alvotech (ALVO)vs › | $2.08B | -36.51% | -21.30% | -316.14% | -299.31% |
| Vericel Corporation (VCEL)vs › | $2.05B | 7.91% | 5.18% | -0.36% | -0.65% |
| Progyny, Inc. (PGNY)vs › | $2.03B | 6.00% | 4.60% | 4.69% | 7.56% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.02B | -40.90% | 5.22% | -37.29% | -215.44% |
| SELLAS Life Sciences Group, Inc. (SLS)vs › | $2.11B | 0.00% | 0.00% | -1032.53% | -880.74% |
| UroGen Pharma Ltd. (URGN)vs › | $2.02B | -51.73% | -140.08% | -143.59% | -315.66% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 100.84% | 51.96% | -5.31% | -103.82% |
| Vera Therapeutics, Inc. (VERA)vs › | $2.11B | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-512.9%
Net Profit Margin
-544.1%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -44760.21% |
| 2026-03-31 | -74397.87% |
| 2025-12-31 | -91178.03% |
| 2025-09-30 | -49.03% |
| 2025-06-30 | -134313.33% |
| 2025-03-31 | -120711.11% |
| 2024-12-31 | -110729.17% |
| 2024-09-30 | -89173.26% |
| 2024-06-30 | -90268.06% |
| 2024-03-31 | -67419.44% |
| 2023-12-31 | -92861.11% |
| 2023-09-30 | -66194.44% |
| 2023-06-30 | -76476.39% |
| 2023-03-31 | -69541.84% |
| 2022-12-31 | -43604.76% |
| 2022-09-30 | -2418.83% |
| 2022-06-30 | -11519.92% |
| 2022-03-31 | -11894.91% |
| 2021-12-31 | -13526.17% |
| 2021-09-30 | -6751.44% |
| 2021-06-30 | -1648.07% |
| 2021-03-31 | -1272.23% |
| 2020-12-31 | -168040.74% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | -3830.36% |
| 2020-03-31 | -971.50% |
| 2019-12-31 | -1149.77% |
| 2019-09-30 | -1615.83% |
| 2019-06-30 | -353.86% |
| 2019-03-31 | -3126.08% |
| 2018-12-31 | -2167.44% |
| 2018-09-30 | -954.56% |
| 2018-06-30 | -399.36% |
| 2018-03-31 | -97.43% |
| 2017-12-31 | -535.74% |
| 2017-09-30 | -357.69% |
| 2017-06-30 | -1018.38% |
| 2017-03-31 | -1510.82% |
| 2016-12-31 | -736.77% |
| 2016-09-30 | -206.86% |
| 2016-06-30 | -286.84% |
| 2016-03-31 | -337.16% |
| 2015-12-31 | -452.20% |
| 2015-09-30 | -629.14% |
| 2015-06-30 | -349.05% |
| 2015-03-31 | -408.37% |
| 2014-12-31 | -345.00% |
| 2014-09-30 | -125.84% |
| 2014-06-30 | -258.25% |
| 2014-03-31 | -64.70% |
| 2013-12-31 | -18.63% |
| 2013-09-30 | -89.43% |
| 2013-06-30 | -48.93% |
| 2013-03-31 | -47.14% |
